Stifel Reiterates Buy Rating on Regenxbio Inc. (RGNX)

May 27, 2026 9:13 AM

Stifel analyst Annabel Samimy reiterated a Buy rating and $42.00 price target on Regenxbio Inc. (NASDAQ: RGNX).The analyst commented, "We ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found